Continuous production of hyaluronic acids is a key trigger to cancer initiation, growth

May 29, 2014 by Alan Flurry
Ying Xu, Regents-Georgia Research Alliance Eminent Scholar and professor of bioinformatics and computational biology, co-authored a study that found that low oxygen levels could be a key driver of cancer growth.

(Medical Xpress)—Chronic inflammation that induces low oxygen levels, or hypoxia, is a widely accepted cause of cancer development. However, the link between hypoxia and cell proliferation is far from clear.

A new study by University of Georgia researchers presents a model explaining the connection between , low oxygen levels and the resulting cell proliferation that begins the process.

"A switch in energy metabolism mechanisms—from the normal oxygenic respiration our cells use to process glucose into energy to a much less efficient, much lower capacity process called anaerobic fermentation—leads to glucose accumulation," said Ying Xu, a Regents-Georgia Research Alliance Eminent Scholar and professor of bioinformatics and computational biology in the UGA Franklin College of Arts and Sciences.

According to the study, this accumulation of glucose and related signaling through the body leads to a reaction much the same as to that of damaged tissue, eventually triggering the cell proliferation that causes cancer. Specifically it leads to synthesis, export and fragmentation of hyaluronic acids, which can serve as signals for tissue repair. The study was published in the online edition of the International Journal of Cancer.

This new research builds on previously published studies authored by Xu's research group establishing low oxygen levels as a primary cause of uncontrollable tumor growth in some cancers.

Consensus thinking on the causes of cancer has centered on genetic mutations, Xu said. But by using gene expression data collected from cancer tissue rather than cancer cell lines, as often used in experimental cancer studies, bioinformatics has enabled researchers broader insight into the metabolic driver as well as key facilitator for cancer initiation that could have great impact on treatment regimes for malignant .

"When you compare statistics like the percentage of cured patients today versus 40 years ago, we can cure more cancer patients, though the primary reason is improvements in early detection," Xu said. "Cancer in its early stages is easier to treat, easier to control."

The focus on chronic inflammation, hypoxia and cell proliferation grew out of a need to understand the conditions connecting the three and why the body allows the growth of cancer cells in much the same way it repairs seemingly healthy cells. This led Xu to compare human tissue with that from a group of organisms that do not develop cancer. This group, including mammals (naked mole rat), as well as amphibians (frogs) and reptiles (turtles), shares an ability to survive in both aerobic and anaerobic environments. They are able to regulate their energy metabolisms according to oxygen availability, an ability to regulate energy demand according to supply never developed by humans.

"When the energy supply drops, our systems do not know how to turn off the energy demand accordingly," Xu said. "So there is an energy gap under persistent hypoxia when we begin to take in excess glucose, which produces glucose accumulation."

The model in the study outlines how the switch of to a less efficient process leads to increased glucose uptake within the cell. This glucose accumulation triggers the synthesis of hyaluronic acid, fragments of which outside the cell become signals for tissue injury and repair, leading to cell proliferation and angiogenesis, which starts the process of continuous —the very initial stage of the cancer process.

"It's a completely logical reaction from within our bodies, and our system is triggered to believe that the tissue is damaged," Xu said. "Cancer begins as a normal, if mistaken, mechanism for cell survival."

The study presents a fundamental reimagining of how cancer begins and could provide the basis for complete rethinking of cancer treatments, especially for late-stage cancer drugs.

"Given my research career as a cancer biologist, I am particularly excited to see this important advance by Dr. Xu and his colleagues," said David Lee, vice president for research at UGA. "The work points to fundamental metabolic changes that may be the primary cause of cancer in multiple tissues. If corroborated by further studies, it could suggest new approaches to cancer prevention and treatment."

Explore further: Low oxygen levels could drive cancer growth

More information: The study is available online: authorservices.wiley.com/bauth … 75&ArticleID=1323464

Related Stories

Low oxygen levels could drive cancer growth

May 3, 2012
Low oxygen levels in cells may be a primary cause of uncontrollable tumor growth in some cancers, according to a new University of Georgia study. The authors' findings run counter to widely accepted beliefs that genetic mutations ...

Non-invasive imaging instead of repeated biopsy in active monitoring of prostate cancer

April 6, 2014
Your body's cells have two major interconnected energy sources: the lipid metabolism and the glucose metabolism. Most cancers feed themselves by metabolizing glucose, and thus can be seen in Positron Emission Topography (PET) ...

Study reveals how cancer cells thrive in oxygen-starved tumors

February 4, 2014
A new study identifies the molecular pathway that enables cancer cells to grow in areas of a tumor where oxygen levels are low, a condition called hypoxia.

Cell metabolism discovery could lead to treatments for cancer, common cold

April 2, 2014
(Medical Xpress)—Scientists at UCLA's Jonsson Comprehensive Cancer Center have published the first study explaining in detail how viruses reprogram the metabolism of the cells they invade to promote continued viral growth ...

Researchers develop new dichloroacetate formulation for cancer treatment

April 16, 2014
Health forums were abuzz in 2007 with news that a simple, inexpensive chemical may serve as a viable treatment to many forms of cancer. The drug dichloroacetate, or DCA, was touted as a cure-all, but after years of work, ...

Discovery of a mechanism that makes tumor cells sugar addicted

April 4, 2014
For almost a hundred years ago is known that cancer cells feel a special appetite for a type of sugar called glucose. The tumor uses this molecule is like the gasoline which depends a sports car to burn faster and grows and ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.